Hearing the words “multiple myeloma” can leave a family with more questions than answers. It is a cancer of the plasma cells inside the bone marrow, and it often progresses slowly enough that careful planning makes a real difference. If you are looking into multiple myeloma treatment in Pune, knowing the warning signs, the tests involved, and the therapy options will help you ask better questions and choose the right path with confidence.
Signs Worth Not Ignoring
Myeloma rarely announces itself loudly. Early signals are easy to mistake for ageing or routine fatigue.
- Bone pain that lingers, usually in the back, ribs, or hips
- Fractures after a minor fall or awkward movement
- Constant tiredness or breathlessness linked to low hemoglobin
- Infections that keep returning or take long to clear
- Excessive thirst, constipation, or mental fogginess from high blood calcium
- Foamy urine or swollen ankles, which can point to kidney strain
- Numbness or tingling in the hands and feet
- Weight loss with no clear reason
Any of these on its own may have a simple explanation. If two or more last beyond a few weeks, consult a cancer specialist in Pune instead of waiting it out.
How Doctors Confirm the Diagnosis and Measure Disease Activity
The first step usually involves blood and urine tests. These look for abnormal proteins produced by myeloma cells, using serum protein electrophoresis, immunofixation, and a free light chain assay. Doctors also check hemoglobin, calcium, and creatinine to see whether the disease is affecting your blood or kidneys. A bone marrow biopsy then confirms the diagnosis by showing what percentage of the marrow is made up of abnormal plasma cells. Genetic testing on the same sample, such as FISH, reveals chromosome changes that influence how aggressive the disease may be.
Imaging comes next. An MRI, PET-CT, or low-dose whole-body CT scan shows bone damage that X-rays often miss. All of this feeds into staging, which combines markers like albumin, beta-2 microglobulin, and LDH with genetic findings. Together, these results shape your multiple myeloma prognosis and help the team decide how urgently and how intensively to treat. Prognosis varies a great deal from person to person, and with modern therapy, many patients now live well for years after diagnosis.
Chemotherapy, Targeted Drugs, and Immunotherapy: How They Differ
Myeloma is seldom treated with one drug alone. Most regimens combine several, and each category has a distinct job.
- Chemotherapy: Melphalan and cyclophosphamide target rapidly dividing cells. Chemo treatment for multiple myeloma is usually paired with steroids, and high-dose melphalan prepares fitter patients for a stem cell transplant. Expect low blood counts, nausea, and a higher risk of infection, so report any fever early.
- Targeted therapy: Bortezomib, carfilzomib, and lenalidomide go after the proteins that myeloma cells depend on to grow. Most people tolerate them better than older chemotherapy, but your doctor will watch for tingling in the feet, skin rashes, and blood clots.
- Immunotherapy: Daratumumab helps the immune system spot myeloma cells. Bispecific antibodies and CAR-T are newer and usually come into the picture only after a relapse, at hospitals that have handled them before.
- Stem cell transplant: Usually offered to patients up to about 70 who are in good general health. It deepens the response achieved with first-line treatment.
- Supportive care: Bone-strengthening medicines, pain relief, radiation for sore bone lesions, and infection prevention are part of every bone marrow cancer treatment in Pune, not an optional extra.
Age, kidney function, genetic risk, and transplant eligibility all influence the plan. Before starting chemotherapy for multiple myeloma in Pune, ask your doctor which side effects are expected, which ones need an urgent call, and who to contact after clinic hours.
Frequently Asked Questions
- Can multiple myeloma be cured?
At present, myeloma is considered controllable rather than curable. Many patients achieve long remissions, and treatment can be repeated or changed if the disease returns. - How long does treatment last?
There is no fixed duration. The induction phase usually spans several months, after which many patients move on to a milder maintenance regimen that can continue for a year or longer. Your response to therapy decides the pace. - Does everyone with myeloma need chemotherapy straight away?
Not necessarily. Patients with smouldering myeloma, an asymptomatic early stage with no organ damage, are generally kept under close observation. Active treatment, including chemo treatment for multiple myeloma, is considered only once symptoms or organ involvement appear. - What should I bring to my first consultation?
Bring every report you have so far, including blood tests, scans, and the biopsy result, along with a list of your current medicines. A brief record of your symptoms and when each one began also helps, since this timeline allows the specialist to gauge how the disease has progressed.
Take the Next Step with Clarity
A diagnosis of myeloma is difficult to absorb, yet the choices made in the early weeks tend to shape the course of treatment for years. Clarity about your stage, your therapeutic options, and the specialists overseeing your care makes those choices far more manageable.
If you or a relative requires direction on multiple myeloma treatment in Pune, the team at Medaccess Health can assist. They help you interpret your reports, connect you with the appropriate specialists, and map out the next phase of care without ambiguity. To begin, visit medaccesshealth.com.